Abstract

In this work we have focused on the ability of interleukin-1 to induce an acute phase protein response and a degranulation of polymorphonuclear leukocytes in vivo. The capacity of the interleukin-1 receptor antagonist to influence these events was also investigated. It was shown that interleukin-1 induced an acute phase protein response in rats and mice. In rats α2-macroglubolin levels were increased in plasma after an interleukin-1 injection whereas α1-inhibitor-3 decreased in plasma. In the mice plasma amyloid P was increased. The interleukin-1 receptor antagonist blocked the increase of α2-macroglobulin and plasma amyloid P in a dose dependent way while the effect on the α1-inhibitor-3 decrease was less pronounced. Interleukin-1 led to polymorphonuclear leukocyte degranulation in vivo as measured by increased cathepsin G plasma levels. The interleukin-1 receptor antagonist could influence the early phase of this degranulation.

Highlights

  • Different forms of tissue injury cause the host to react with a uniform acute phase response

  • When diisopropylfluorophosphate inactivated cathepsin G was added to normal rat plasma 90% of the added amount could be measured with the assay

  • In this study we have focused on the ability of IL-1 to induce an acute phase protein response and degranulation of polymorphonuclear leukocyte (PMN) in vivo

Read more

Summary

Introduction

Different forms of tissue injury cause the host to react with a uniform acute phase response This acute phase response is effected by a variety of mediators including different cytokines. Interleukin-1 (IL-1), interleukin-6 (IL-6) and turnout necrosis factor 0 (TNF 0) have been shown to hold central positions in the acute phase response.[2] Several plasma proteins are increased or decreased as a part of the acute phase response. This acute phase protein response differs from species to species. Their main function is to inhibit polymorphonuclear leukocyte (PMN) cathepsin G and elastase, respectively

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.